Chicago, May 15, 2025 (GLOBE NEWSWIRE) -- The global multiple myeloma market is witnessing steady growth, fuelled by an aging population, rising disease prevalence, and continuous advancements in ...

A multiple myeloma diagnosis is a life event that can be overwhelming. Get trusted information for every step of your journey. Multiple myeloma can be tricky. That’s because it sometimes has no ...

Her treatment consisted of rhubarb pills and an infusion of orange peels. Now, 181 years later, multiple myeloma remains incurable, with most patients eventually relapsing or developing treatment ...

It’s true that we’ve come a long way in recent years when it comes to treating multiple myeloma. More therapies are being developed, to the point where somebody diagnosed now is likely to have ...

Despite being the second most common haematologic cancer globally, treatment options for multiple myeloma remain limited, with a significant need for new therapies. 1 Multiple myeloma originates i ...

Supported in part by the GSRT Operational Program “Competitiveness, Entrepreneurship, & Innovation (EPAnEK) 2014-2020.” Presented in part in the 61st American Society of Hematology (ASH) annual ...

In multiple myeloma, abnormal plasma cells build up inside bone marrow -- the spongy tissue inside large bones where blood cells are produced. Over time, myeloma cells cause damage to bones ...

gastric cancer), as well as multiple blood cancers (multiple myeloma, large B-cell lymphoma, indolent non-Hodgkin lymphoma, acute lymphoblastic leukemia). At EHA, Kite and its partner Arcellx will ...

C4 Therapeutics, Inc. (C4T) announced promising results from the latest data on its investigational drug cemsidomide for treating multiple myeloma, showing a 50% overall response rate (ORR ...

We have seen effective and efficient mobilization with GPC-100 in combination with G-CSF and propranolol in our multiple myeloma patients, with an excellent safety profile. We look forward to the ...